Herbal Topical Analgesic for Pain Management: Perspectives from Cancer Patients
- PMID: 33620470
- PMCID: PMC8185551
- DOI: 10.1093/pm/pnab072
Herbal Topical Analgesic for Pain Management: Perspectives from Cancer Patients
Abstract
Objective: Herbs and natural products are increasingly used by cancer patients for pain management, but few studies have examined their integration within conventional cancer care. This study describes the characteristics, experiences, and perspectives of cancer patients who were prescribed an herbal topical analgesic for pain management.
Design and setting: Program evaluation of a pilot herbal dispensary at a National Cancer Institute-designated comprehensive cancer center.
Subjects: Cancer patients who were prescribed the Tibetree Pain-Relieving Plaster (PRP) by an integrative medicine physician.
Methods: Sociodemographic and clinical characteristics of patients were abstracted from medical records. Semistructured phone interviews were conducted 1-2 weeks after PRP prescription to evaluate patient experiences with using PRP for pain. Interviews were analyzed through thematic content analysis.
Results: From February 2019 to February 2020, 50 patients were prescribed PRP. Median age (range) was 63 years (21-86), 37 patients (74%) were female, 14 (28%) were non-White, and 38 (76%) were using oral analgesics. During interviews, the majority of patients reported that the PRP improved pain and health-related outcomes, was convenient to use, and addressed pain management needs that were not fulfilled by oral analgesics. However, a few patients described adverse experiences with PRP, including skin irritation.
Conclusions: Understanding patient experiences and perspectives is a critical step toward evidence-based integration of herbs and natural products into cancer pain management. Findings from this program evaluation will inform the design of a randomized clinical trial on the efficacy and safety of PRP for pain in patients with cancer.
Keywords: Cancer; Herbs; Integrative Medicine; Natural Products; Pain Management.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
A Systematic Review of CheeZheng Pain Relieving Plaster for Musculoskeletal Pain: Implications for Oncology Research and Practice.Integr Cancer Ther. 2020 Jan-Dec;19:1534735420918933. doi: 10.1177/1534735420918933. Integr Cancer Ther. 2020. PMID: 32880472 Free PMC article.
-
Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group.Ann Intern Med. 1993 Jul 15;119(2):121-6. doi: 10.7326/0003-4819-119-2-199307150-00005. Ann Intern Med. 1993. PMID: 8099769
-
Prevalence of analgesic prescriptions among patients with cancer in Japan: an analysis of health insurance claims data.Glob J Health Sci. 2012 Oct 12;4(6):197-203. doi: 10.5539/gjhs.v4n6p197. Glob J Health Sci. 2012. PMID: 23121757 Free PMC article.
-
Effectiveness of Taiwanese traditional herbal diet for pain management in terminal cancer patients.Asia Pac J Clin Nutr. 2008;17(1):17-22. Asia Pac J Clin Nutr. 2008. PMID: 18364321 Clinical Trial.
-
Adjuvant analgesics in cancer pain: a review.Am J Hosp Palliat Care. 2012 Feb;29(1):70-9. doi: 10.1177/1049909111413256. Epub 2011 Jun 28. Am J Hosp Palliat Care. 2012. PMID: 21712306 Review.
Cited by
-
Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL/6 Mice.Evid Based Complement Alternat Med. 2021 Aug 10;2021:4120334. doi: 10.1155/2021/4120334. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34422067 Free PMC article.
-
Tibetan Herbal Pain-Relieving Plaster for Chronic Musculoskeletal Pain Among Cancer Survivors: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled Trial.Front Pharmacol. 2022 May 4;13:878371. doi: 10.3389/fphar.2022.878371. eCollection 2022. Front Pharmacol. 2022. PMID: 35600872 Free PMC article.
-
A Randomized, Double-Blind, Placebo-Controlled Trial Protocol Using the Fuzhengxiaoliu Patch for the Management of Primary Liver Cancer Pain.J Pain Res. 2025 Jan 6;18:33-42. doi: 10.2147/JPR.S500305. eCollection 2025. J Pain Res. 2025. PMID: 39802415 Free PMC article.
-
Topical Traditional Chinese Medicines for Cancer Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Integr Cancer Ther. 2023 Jan-Dec;22:15347354231210870. doi: 10.1177/15347354231210870. Integr Cancer Ther. 2023. PMID: 37962002 Free PMC article.
References
-
- Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA: Cancer J Clin 2019;69(5):363–85. - PubMed
-
- Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2019. CA: Cancer J Clin 2019;69(1):7–34. - PubMed
-
- van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007;18(9):1437–49. - PubMed
-
- van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ.. Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. J Pain Symptom Manag 2016;51(6):1070–90.e9. - PubMed
-
- Zylla D, Steele G, Gupta P.. A systematic review of the impact of pain on overall survival in patients with cancer. Support Care Cancer 2017;25(5):1687–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials